CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1995; 45:244
doi: 10.3322/canjclin.45.4.244
© 1995 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hetelekidis, S.
Right arrow Articles by Harris, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hetelekidis, S.
Right arrow Articles by Harris, J. R.

CA: A Cancer Journal for Clinicians, Vol 45, Issue 4 244-253, Copyright © 1995 by American Cancer Society


ARTICLES

Management of ductal carcinoma in situ

S. Hetelekidis, S. J. Schnitt, M. Morrow and J. R. Harris
Joint Center for Radiation Therapy, Harvard Medical School in Boston, Massachusetts, USA.

The increased use of screening mammography in the past two decades has led to a marked increase in the number of patients diagnosed with ductal carcinoma in situ. Treatment has traditionally involved mastectomy, but this approach has come under increasing scrutiny, and the treatment of ductal carcinoma in situ has become one the most controversial areas in the field of breast disease. This article reviews current concepts regarding the diagnosis, natural history, and treatment of ductal carcinoma in situ.


This article has been cited by other articles:


Home page
JCOHome page
C. Mazouni, F. Peintinger, S. Wan-Kau, F. Andre, A. M. Gonzalez-Angulo, W. F. Symmans, F. Meric-Bernstam, V. Valero, G. N. Hortobagyi, and L. Pusztai
Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome
J. Clin. Oncol., July 1, 2007; 25(19): 2650 - 2655.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. Kerlikowske, A. Molinaro, I. Cha, B.-M. Ljung, V. L. Ernster, K. Stewart, K. Chew, D. H. Moore II, and F. Waldman
Characteristics Associated With Recurrence Among Women With Ductal Carcinoma In Situ Treated by Lumpectomy
J Natl Cancer Inst, November 19, 2003; 95(22): 1692 - 1702.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by American Cancer Society.